A Father’s Journey and Fight Towards a Cure for MPS I Rare Disease

 

About this Podcast: 

In this episode, Mark Dant, Founder of the Ryan Foundation speaks with Steve Smith, WCG’s President of Patient Advocacy. Their conversation highlights the importance of Patient Advocacy Groups – and the resources they bring to individuals diagnosed with a disease – as well as the great promise clinical trials bring to patients. Mark shares a personal story of his son, Ryan, who was diagnosed with MPS I, and how Patient Advocacy Groups and clinical trials have positively impacted their lives.

About the Author

Steve Smith | President, Patient Advocacy, WCG

Steve Smith is a seasoned patient advocate with an extensive career in software, consulting, process transformation, health care systems and patient-focused drug development. He joined WCG as President Patient Advocacy in 2019 inspired by the incredible value to patients embedded in the wide range of WCG solutions that reduce the time and cost of clinical trials.

Visit Website More Content by Steve Smith | President, Patient Advocacy, WCG
Previous Post
An Inside Look at Ehlers-Danlos Syndrome: An Interview with Sarah Tompkins
An Inside Look at Ehlers-Danlos Syndrome: An Interview with Sarah Tompkins

Next Post
An Inside Look at Angelman Syndrome Rare Disease with Advocate Amanda Moore
An Inside Look at Angelman Syndrome Rare Disease with Advocate Amanda Moore